has been cited by the following article(s):
[1]
|
Report from the 2018 consensus conference on immunomodulating agents in thoracic transplantation: Access, formulations, generics, therapeutic drug monitoring, and special populations
The Journal of Heart and Lung Transplantation,
2020
DOI:10.1016/j.healun.2020.06.024
|
|
|
[2]
|
Transition from brand to generic tacrolimus is associated with a decrease in trough blood concentration in pediatric heart transplant recipients
Pediatric Transplantation,
2015
DOI:10.1111/petr.12608
|
|
|
[3]
|
Safety and efficacy of the switch to generic mycophenolate mofetil and tacrolimus in heart transplant patients
Clinical Transplantation,
2015
DOI:10.1111/ctr.12564
|
|
|
[4]
|
Transition from brand to generic tacrolimus is associated with a decrease in trough blood concentration in pediatric heart transplant recipients
Pediatric Transplantation,
2015
DOI:10.1111/petr.12608
|
|
|
[5]
|
Safety and efficacy of the switch to generic mycophenolate mofetil and tacrolimus in heart transplant patients
Clinical Transplantation,
2015
DOI:10.1111/ctr.12564
|
|
|
[6]
|
Generic tacrolimus in solid organ transplantation
Clinical Transplantation,
2014
DOI:10.1111/ctr.12336
|
|
|
[7]
|
Generic tacrolimus in solid organ transplantation
Clinical Transplantation,
2014
DOI:10.1111/ctr.12336
|
|
|